Ken Cacciatore
Stock Analyst at TD Cowen
(0)
# 4987
Out of 5,331 analysts
17
Total ratings
27.27%
Success rate
-31.47%
Average return
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ARQT Arcutis Biotherapeut... | Maintains: Outperform | 65 50 | 15.23 | 228.3% | 2 | Aug 9, 2023 | |
BHC Bausch Health Compan... | Downgrades: Market Perform | n/a | n/a | n/a | 1 | Jun 16, 2023 | |
TAK Takeda Pharmaceutica... | Maintains: Outperform | 30 20 | 15.31 | 30.63% | 4 | May 16, 2023 | |
ISEE IVERIC bio | Downgrades: Market Perform | n/a | n/a | n/a | 2 | May 8, 2023 | |
SCPH scPharmaceuticals | Initiates Coverage On: Outperform | 25 | 2.6 | 861.54% | 1 | Dec 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 35 | 11.44 | 205.94% | 1 | May 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 50 | 4.06 | 1131.53% | 1 | Jul 13, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 50 | 3.57 | 1300.56% | 1 | Oct 19, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 45 | 22.79 | 97.46% | 1 | Apr 17, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 460 | 10.9 | 4120.18% | 1 | Mar 2, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 375 | 9.39 | 3893.61% | 1 | Dec 18, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | Sep 22, 2017 |